Immunic Inc (NAS:IMUX)
$ 1.3 0.02 (1.56%) Market Cap: 117.10 Mil Enterprise Value: 19.12 Mil PE Ratio: 0 PB Ratio: 1.40 GF Score: 43/100

Q2 2022 Immunic Inc Earnings Call Transcript

Aug 04, 2022 / 12:00PM GMT
Release Date Price: $4.79 (+23.14%)
Jessica Breu
Immunic, Inc. - Head of IR & Communications

Good morning, everybody, and welcome to Immunic's Second Quarter 2022 Earnings Call. My name is Jessica Breu, Head of Investor Relations and Communications at Immunic. I will also be the moderator on today's call.

Speaking on the call are Dr. Daniel Vitt, our Chief Executive Officer and President; as well as Glenn Whaley, our Chief Financial Officer. For the Q&A section of today's webcast, we also have with us our Chief Scientific Officer, Dr. Hella Kohlhof. (Operator Instructions) This event is being recorded.

(Operator Instructions) Before we begin, I would like to remind you that this presentation may contain forward-looking statements. Such statements can be identified by words such as may, will, expect, anticipate, estimate or words with similar meaning, and such statements involve a number of risks and uncertainties that could cause Immunic's actual results to differ materially from those discussed here. Please note that these forward-looking statements reflect the Immunic's opinions only as of the date of this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot